secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0000012208-25-000025
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad Q1 revenue falls 4% to $585M; full-year 2025 outlook moderated on uncertainty
--------------------------------------------------------------------------------

- Revenue $585.4M, down from $610.8M YoY; GAAP gross margin 52.3% vs 53.4%.
- GAAP net income $64.0M ($2.29 EPS) vs $383.9M ($13.45 EPS) in Q1 2024.
- Non-GAAP net income $71.0M ($2.54 EPS) vs $65.3M ($2.30 EPS) YoY.
- CEO cites market uncertainty; moderating full-year 2025 outlook.
- Non-GAAP gross margin 53.8%, slightly down from 54.2% a year ago.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220825000025/0000012208-25-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220825000025/bio-20250501.htm
  HTML page:      https://secwatch.observer/filing/0000012208-25-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer